knowledge -WSS

knowledge

author：hotspot 2025-09-30 23:45:26 - browse：468

Adobe

WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Palantir health business leans on meeting customers’ needs

leisure time

WSS

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Hearing on Medicare drug price negotiation gets unusually heated

FDA panel to weigh approval of NurOwn, controversial ALS drug

Thermo Fisher plant for manufacturing gene therapies to expand

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

leisure time

knowledge

focus

Peter Hotez and the public health issue of online harassment

Biotech lab space demand falls sharply

State Dept. review finds Biden bears some blame for Afghanistan failures

Senators: Long

Peter Hotez and the public health issue of online harassment

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

In age of alternative facts, a scholarly course on calling out crap

Second xenotransplant done with gene

New air purifier tech could be key to improving indoor air quality

Petition to FDA: Get the lead out of consumer hair dyes

focus

Senate HELP committee spars over health care workforce policies

Petition to FDA: Get the lead out of consumer hair dyes

Why 40% Americans with Parkinson’s don’t see a neurologist

Study: Pain burden is higher in Black NFL players than white ones

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

How the political right came to back psychedelics to treat trauma

hotspot

leisure time

entertainment

knowledge